What's the Cost of Neuroblastoma Diagnosis and Treatment in India?
Neuroblastoma treatment cost in India typically runs from AUD $60 to AUD $150 for initial specialist reviews, with complex treatment of neuroblastoma ranging from AUD $24,200 to AUD $45,300. Total expenses depend on the cancer risk level and the need for advanced therapies. Patients save approximately 70% to 80% compared to Australia and the US. Top treatment hubs include Mumbai, Bengaluru, and Delhi.
Typical Neuroblastoma Treatment Costs in India
- Consultation with an oncologist: AUD $60 โ AUD $150
- Consultation with a pediatrician: AUD $45 โ AUD $91
- Bone marrow biopsy: AUD $420 โ AUD $650
- Complex treatment of neuroblastoma: AUD $24,200 โ AUD $45,300
- CAR NK cell therapy: Price on request
Bookimed Expert Insight: Advanced neuroblastoma cases benefit from multidisciplinary centres like Global Hospital Chennai, which specializes in complex bone marrow transplants. For patients needing the latest protocols, Fortis Gurgaon is ranked as one of the most technically advanced hospitals globally. Families seeking integrated care should consider HCG Manavata Cancer Centre, where over 40 consultant oncologists use immunotherapy to treat pediatric solid tumours.
| India | Thailand | Turkey | |
|---|---|---|---|
| Complex treatment of neuroblastoma | โ AUD $24,200 | โ AUD $45,300 | โ AUD $57,400 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees โ just official clinic prices. Pay at the clinic for Neuroblastoma treatment and use a flexible instalment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Neuroblastoma treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Neuroblastoma treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Neuroblastoma Treatment Centres in India for Australians: 6 Verified Options and AUD Prices
HCG Manavata Cancer Centre
Raj Nagarkar




Get a Medical Assessment for Neuroblastoma in India: Consult with Experienced Doctors Now
View all Doctors
Gaurav Kharya
Expert pediatric hematologist-oncologist specializing in neuroblastoma at Artemis Hospitals.
- Specializes in bone marrow transplants for pediatric cases
- Focuses on advanced treatment for neuroblastoma
- Works at a renowned facility with cutting-edge technology

Shruti Kate
Dr. Shruti Kate specializes in pediatric tumors, including neuroblastoma, with training at Tata Memorial Hospital โ India's leading cancer center.
- DM in Medical Oncology from Tata Memorial Hospital
- Expert in immunotherapy and metronomic therapy for advanced cancers
- Member of ASCO, ESMO, and other top oncological societies
- Presented lung cancer research at World Conference on Lung Cancer

Raj Nagarkar
Dr. Raj Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre. He specializes in breast and thoracic surgical oncology. Dr. Nagarkar trained at the prestigious Tata Memorial Hospital in Mumbai. He is a Member of the Royal College of Surgeons in Edinburgh.
- Participated as a lead investigator in more than 200 clinical trials.
- Serves as a professor for DNB Superspecialty Surgical Oncology.
- Expert in complex procedures including mastectomy and thoracic resections.
- Founder of Curie Manavata Cancer Centre, a major regional treatment hub.

Deenadayalan Munirathnam
The doctor is a pediatric hematologist-oncologist with a specialization in bone marrow transplantation. They have extensive experience in treating complex blood disorders and cancers in children. Their clinical focus includes the management of pediatric leukemia, lymphoma, and other hematologic malignancies. The doctor is recognized for their expertise in performing bone marrow transplants and has contributed to advancements in pediatric oncology through clinical research and innovation.
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Neuroblastoma Treatment in India
What is the survival rate for neuroblastoma in India?
Survival rates for neuroblastoma in India vary significantly between 8.7% and 80%. The rate depends largely on the disease stage at diagnosis. Localised cases show high survival. However, advanced stage IV cases often report a 2-year survival rate of approximately 30%. This low rate is due to late detection.
- Stage variation: Outcomes range from 8.7% to 80% depending on risk category and diagnosis stage.
- Advanced cases: Children with high-risk disease show a projected 2-year survival rate near 30%.
- Specialised centres: Facilities like HCG Manavata Cancer Centre perform 65,000+ cancer surgeries to improve outcomes.
- Expert care: Specialists like Dr Shruti Kate train at premier institutions like Tata Memorial Hospital.
Bookimed Expert Insight: Clinical volume is a major indicator of quality in Indian oncology. HCG Manavata Cancer Centre has treated 25,000+ radiotherapy patients and maintains a US-FDA-audited research institute. Choosing centres with high paediatric caseloads and JCI accreditation, such as BLK Super Speciality Hospital. This provides access to international safety standards. These high-volume hubs are better equipped to manage the intensive treatment protocols required for stage III and IV neuroblastoma.
Are there experimental treatments available for relapsed neuroblastoma in India?
India provides several treatments for relapsed neuroblastoma. Specialists offer CAR NK cell therapy and MIBG targeted radiotherapy. Immunotherapy and metronomic therapy are available at major oncology hubs. These centres follow international protocols for complex paediatric cases and stem cell rescue.
- Advanced radiotherapy: HCG Manavata Cancer Centre uses TomoTherapy-H and Versa HD technology.
- Clinical research: The Manavata Clinical Research Institute is audited by the US-FDA.
- Expert specialists: Dr Shruti Kate at HCG Manavata trained at Tata Memorial Hospital.
- Bone marrow transplant: Global Hospital Chennai and BLK Super Speciality specialise in transplants.
Bookimed Expert Insight: Indian oncology centres often provide treatments like metronomic therapy and immunotherapy at 30% to 50% lower costs than European clinics. This makes continuous, long-term protocols more accessible for international families. Centres such as HCG Manavata have performed over 65,000 cancer surgeries, demonstrating extensive clinical experience with complex tumours.
Patient Consensus: Patients note that primary oncologists are the best resource for finding trials. Families should specifically ask about clinical protocols for high-risk relapses in India.
How are children monitored after neuroblastoma treatment in India?
Children in India undergo a structured follow-up program featuring clinical exams, blood tests, and imaging to detect recurrence. Monitoring typically follows the International Neuroblastoma Staging System. Specialists use contrast-enhanced CT or MRI scans and MIBG scans. These scans track high-risk cases after treatment ends.
- Imaging schedule: Regular scans like MRI or CECT monitor the abdomen and pelvis for changes.
- Surveillance: Specialists at HCG Manavata Cancer Centre use PET-CT and Gamma Camera for tracking.
- Late-effect checks: Doctors assess growth, development, and hearing via Brainstem-evoked response audiometry after high-risk periods.
- Staging protocols: Follow-up frequency and tests are determined by International Neuroblastoma Risk Group Staging standards.
Bookimed Expert Insight: Indian cancer centres like HCG Manavata Cancer Centre often maintain US-FDA audited research units. This is notable as doctors such as Dr Shruti Kate are members of international bodies like ASCO. This global alignment means children receive monitoring protocols matching Australian or European standards. These protocols are for high-risk neuroblastoma.
Patient Consensus: Parents note that follow-up scans often continue for 3 years post-treatment. They highlight the need for families to be proactive advocates. Families should have every scan result scrutinised in India.













